
Arm Holdings plc American Depositary Shares
Technology · USD
Price
$148.77
Cap
$158.3B
Earnings
4/4 beat
30d Trend
-4%
Upper half of range — momentum is positive
Target range: $95 – $240 (consensus: $165.01)
Consensus: Buy
Earnings history
Q3 2026
BEAT
0.43 vs 0.41
Q2 2026
BEAT
0.39 vs 0.33
Q1 2026
BEAT
0.35 vs 0.34
Q4 2025
BEAT
0.55 vs 0.52
Key macro factors
Accelerated AI and Data Center Demand: Arm is heavily investing and expanding into AI and data center solutions with new CPU designs (AGI CPU) and strategic partnerships (e.g., IBM). This aligns with the global surge in AI processing power and cloud infrastructure, directly boosting Arm's licensing and royalty revenues due to its energy-efficient architectures.
Global Semiconductor Supply Chain Stability & Geopolitical Tensions: As a foundational IP provider in the semiconductor industry, Arm's business is highly dependent on the stability of global chip manufacturing and sales by its partners. Escalating geopolitical conflicts, such as those in the Middle East, can disrupt global supply chains, increase manufacturing costs (e.g., due to surging oil prices impacting logistics), or lead to trade barriers, all of which could negatively impact the production and adoption of Arm-based chips.
Inflation, Interest Rates, and Consumer/Enterprise Spending: Macroeconomic indicators like US CPI and PCE inflation data directly influence central bank decisions on interest rates. Elevated interest rates can raise borrowing costs for businesses (including Arm's licensees and end-product customers), potentially dampening investment in new technologies, reducing consumer demand for electronics, or slowing overall enterprise IT spending, thereby affecting Arm's overall licensing and royalty income.
Arm Holdings plc architects, develops, and licenses central processing unit (CPU) products and related technologies for semiconductor companies and original equipment manufacturers across various markets including mobile, IoT, automotive, and data centers.
QUANT SCORE
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.
